Hypoxia-Inducible Factor 1-Alpha Regulates Cancer-Inhibitory Effect of Human Mesenchymal Stem Cells

Yuan Hu1, Jing Bai2, Shu-Xun Hou3

  • 1Institute of Orthopedics, The First Affiliated Hospital of Chinese PLA General Hospital, 51 Fucheng Road, Haidian District, Beijing, 100048, China. yuanh1998@163.com.

Insights

Hypoxia-inducible factor 1-alpha (HIF-1α) in mesenchymal stem cells (MSCs) inhibits breast cancer cell growth. Depleting HIF-1α promotes cancer cell proliferation, while overexpressing it inhibits growth, linked to p21 levels.

Area of Science:

  • Cancer Biology
  • Stem Cell Research
  • Molecular Mechanisms

Background:

  • Mesenchymal stem cells (MSCs) exhibit anti-cancer properties.
  • The role of hypoxia-inducible factor 1-alpha (HIF-1α) in MSC-mediated cancer inhibition is not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanism of HIF-1α in human MSCs' inhibition of breast cancer cell proliferation.
  • To determine the impact of HIF-1α depletion and overexpression in MSCs on cancer cell growth.

Main Methods:

  • Human MSCs (Z3 cells) were manipulated for HIF-1α depletion and overexpression.
  • The effect of MSC culture medium on breast cancer MCF-7 cell proliferation and colony formation was assessed.
  • Expression levels of cell cycle proteins p21 and p53 in MCF-7 cells were analyzed.

Main Results:

  • HIF-1α-depleted MSC medium promoted MCF-7 cell proliferation and colony formation, with increased p21 expression.
  • HIF-1α-overexpressed MSC medium inhibited MCF-7 cell proliferation and colony formation, with decreased p21 expression.
  • p53 levels remained unchanged in MCF-7 cells in both conditions.

Conclusions:

  • HIF-1α in human MSCs promotes the inhibition of breast cancer cell proliferation and colony formation.
  • This inhibitory effect is closely correlated with the regulation of the cell cycle protein p21 in cancer cells.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K